Keywords: Preclinical Image Analysis, Electron Paramagnetic Resonance
Motivation: EPR oximetry using Ox071 holds promise in detecting chemotherapy-induced chronic kidney injury by monitoring pO2 distribution.
Goal(s): Using EPR, our study assessed the ability to discern pO2 variations between healthy kidneys and kidney injury models induced by intraperitoneal cisplatin treatment.
Approach: To validate these changes, we performed longitudinal EPR-based pO2 imaging.
Results: The analysis of EPR oximetry results consistently showed renal hypoxia two months after treatment, which aligns with kidney fibrosis confirmed by the ex vivo protein assay.
Impact: Traditionally, EPR oximetry has concentrated on tumor hypoxia due to Ox063’s limitations in well-oxygenated tissues. Using Ox071, a deuterated analog, this research broadens the application of oximetry to kidneys, where hypoxic changes serve as a critical indicator of fibrosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords